Intuitive Surgical (ISRG US) posted 3Q24 result, with revenue, procedure volume growth, system placement, and EPS beating estimates. Accelerating rollout of da Vinci 5 remains one of the growth engines.
During 3Q24, Intuitive placed 110 da Vinci 5 systems, up from 70 in Q2 and eight in Q1. da Vinci 5 system has been used in more than 12,000 procedures.
Intuitive has raised the low end of the procedure growth guidance range from 15.5% to 16.0% and expects full year 2024 procedure growth within a range of 16% and 17%.
Begin exploring Smartkarma's AI-augmented investing intelligence platform with a complimentary Preview Pass to:
Unlock research summaries
Follow top, independent analysts
Receive personalised alerts
Access Analytics, Events and more
Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.